IP Library Granted Patent US 11,376,300
Granted Patent B2
US 11,376,300 · App. 16/430,395 · Granted Jul 5, 2022

Compositions and methods for the treatment of plaques and tangles in humans and animals

Inventors: Judy Cam (Bellevue, WA); Thomas Lake (Snohomish, WA); Qubai Hu (Kirkland, WA); Joel Cummings (Seattle, WA); Alan D Snow (Lynnwood, WA)
Assignee: COGNITIVE CLARITY INC.
A61K36/82A61K36/74
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,376,300
App. No.
16/430,395
Granted
Jul 5, 2022
Kind
B2
Abstract

Composition and methods for treating brain “plaques” and “tangles” in a patient or an animal wherein the method comprises administration of a therapeutically effective amount of a composition comprising Uncaria tomentosa extract and an oolong tea extract.

Claims (10)

1. A composition comprising a therapeutically effective amount of an Uncaria tomentosa extract for treating beta-amyloid containing plaques and tau protein containing tangles in a mammal and a therapeutically effective amount of an oolong tea extract for treating beta-amyloid containing plaques and tau protein containing tangles in a mammal, wherein the composition is formulated for oral administration, and wherein the composition contains 100-500 mg of the Uncaria tomentosa extract and 100-500 mg of the oolong tea extract.

2. The composition of claim 1 , wherein composition is a pill, a tablet, a caplet, a soft gelatin capsule, a hard gelatin capsule, a lozenge, a sachet, a cachet, a vegicap, liquid drops, an elixir, a suspension, an emulsion, a solution, a syrup, or a tea bag.

3. The composition of claim 1 , wherein the Uncaria tomentosa extract and the oolong tea extract are in the form of a lyophilized powder.

4. The composition of claim 1 , wherein the composition is an aqueous suspension, a dispersible powder or granules.

5. The composition of claim 2 , wherein the composition further comprises a dispersing agent, a wetting agent, or a suspending agent.

6. The composition of claim 1 , wherein the composition comprises an oily suspension or an oil-in-water emulsion, wherein the oil phase comprises the therapeutically effective amount of the Uncaria tomentosa extract and the therapeutically effective amount of the oolong tea extract.

7. The composition of claim 6 , wherein the composition further comprises an emulsifying agent.

8. The composition of claim 1 , wherein the composition is formulated for delayed release after oral administration.

9. The composition of claim 8 , wherein the composition is a tablet or a capsule.

10. The composition of claim 9 , wherein the tablet is a coated tablet that delays absorption in the gastrointestinal tract.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2022
From: CAM, JUDY; LAKE, THOMAS; HU, QUBAI; CUMMINGS, JOEL; SNOW, ALAN D
To: COGNITIVE CLARITY INC.
Reel/Frame 060024/0292 →
Continuity (5)
Continuation 15669443 · Aug 4, 2017
Continuation 15053572 · Feb 25, 2016
Provisional Application 62170822 · Jun 4, 2015
Provisional Application 62126026 · Feb 27, 2015
Related Publication 20190350996A1 · Nov 21, 2019